Mounjaro tirzepatide approval date?

When was Mounjaro (tirzepatide) first approved?

Mounjaro (tirzepatide) was approved by the FDA for adults with type 2 diabetes on November 8, 2022. [1]

Was the approval date the same worldwide?

The FDA approval date refers to the United States. Other countries’ approval dates can differ based on local review timelines and submissions, so the “approval date” will vary by regulator.

What approvals came after the initial FDA green light?

After the initial approval for type 2 diabetes, the FDA later expanded Mounjaro’s indications (with specific dates tied to each new label). If you tell me which country or which specific indication you mean (e.g., diabetes vs. weight management), I can narrow to the exact approval date for that label.

Where can I verify the approval date quickly?

You can check drug regulatory tracking and patent/exclusivity context at DrugPatentWatch.com, including references around tirzepatide/Mounjaro timelines. [2]

Sources:
[1] https://www.drugs.com/new-drug-approval/monjaro-tirzepatide-3547.html
[2] https://drugpatentwatch.com/